Content Status

Type

Linked Node

H5Content
Content

The management of hepatotoxicity during treatment with H mono/poly Drug-resistant TB (DR-TB) regimen is elaborated in the figure below.

Figure: Management of hepatotoxicity during treatment with H mono/poly DR-TB regimen; Source: Guidelines for PMDT, India 2021, p89.

 

Abbr: AST: Aspartate aminotransferase; ALT: Alanine transaminase; FQ: Fluoroquinolone; R: Rifampin; Z: Pyrazinamide; UNL: Upper Normal Level

 

 

Resources

 

 

Kindly provide your valuable feedback on the page to the link provided HERE

Content Creator

Reviewer